Gross profit in 1HFY2024 also decreased by 8.50% y-o-y, mainly due to an increase in the cost of inventories, consumables and surgery expenses.
HC Surgical Specialists (HCSS) (SGX:1B1
) has reported earnings at $3.5 million for its 1HFY2024 ended Nov 30, a 68.3% increase from its $2.1 million earnings in the same period last year, after booking fair value gains on its investments in other listed companies.
For the same period, earnings per share rose 65.9% to 2.29 cents from 1.38 cents in 1HFY2023, while revenue fell 4.9% y-o-y to $9.6 million from $10.1 million.
